FDA approves Meridian Bioscience's test for herpes in newborns

FDA approves Meridian Bioscience's test for herpes in newborns


REUTERS: The U.S. Food and Drug Administration approved on Friday the first test: a diagnostic from Meridian Bioscience Inc: to help detect a type of herpes virus in newborns. Meridian's Alethia CMV Assay Test System detects cytomegalovirus DNA from saliva swabs and won approval for use in babies younger than 21 days of age infected during pregnancy.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога